Philip Morris International Investing Cash Flow increased by 99.3% to -$3.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 99.3%, from -$434.00M to -$3.00M. Over 3 years (FY 2021 to FY 2025), Investing Cash Flow shows a downward trend with a 18.9% CAGR.
A negative value typically signals investment in future growth, while a positive value may indicate divestment or the maturity of a large investment portfolio.
This metric is the net total of all cash inflows and outflows related to investing activities, including capital expendi...
Most mature healthcare companies maintain a negative net investing cash flow due to ongoing R&D and infrastructure investment.
net_cash_from_investing| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$183.00M | -$1.89B | -$340.00M | -$196.00M | $0.00 | -$96.00M | -$15.53B | -$591.00M | -$483.00M | -$1.96B | -$568.00M | -$193.00M | -$337.00M | -$1.00B | -$434.00M | -$2.32B | -$789.00M | -$428.00M | -$3.00M |
| QoQ Change | — | -932.8% | +82.0% | +42.4% | +100.0% | — | <-999% | +96.2% | +18.3% | -305.0% | +71.0% | +66.0% | -74.6% | -197.6% | +56.7% | -433.6% | +65.9% | +45.8% | +99.3% |
| YoY Change | — | — | — | — | +100.0% | +94.9% | <-999% | -201.5% | — | <-999% | +96.3% | +67.3% | +30.2% | +48.7% | -124.9% | -587.2% | +21.3% | — | +99.3% |